1. Home
  2. HSTM vs VALN Comparison

HSTM vs VALN Comparison

Compare HSTM & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HealthStream Inc.

HSTM

HealthStream Inc.

HOLD

Current Price

$21.57

Market Cap

642.6M

Sector

Technology

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$5.57

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HSTM
VALN
Founded
1990
2012
Country
United States
France
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
642.6M
536.9M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
HSTM
VALN
Price
$21.57
$5.57
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$28.00
$15.50
AVG Volume (30 Days)
160.5K
126.2K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
0.65%
N/A
EPS Growth
N/A
N/A
EPS
0.61
N/A
Revenue
$304,064,000.00
N/A
Revenue This Year
$9.45
N/A
Revenue Next Year
$5.12
$93.87
P/E Ratio
$35.18
N/A
Revenue Growth
4.26
N/A
52 Week Low
$19.50
$5.15
52 Week High
$34.13
$12.25

Technical Indicators

Market Signals
Indicator
HSTM
VALN
Relative Strength Index (RSI) 57.37 28.77
Support Level $20.99 N/A
Resistance Level $21.72 $6.42
Average True Range (ATR) 0.53 0.28
MACD 0.09 0.09
Stochastic Oscillator 84.77 26.77

Price Performance

Historical Comparison
HSTM
VALN

About HSTM HealthStream Inc.

HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: